These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 1688295)
61. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? Gompels MM; Simpson N; Snow M; Spickett G; Ong E J Infect; 1999 Mar; 38(2):111-5. PubMed ID: 10342651 [TBL] [Abstract][Full Text] [Related]
62. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus. Phair JP; Masur H; Gross PA; Holmes KK; Kaplan JE Clin Infect Dis; 1995 Aug; 21 Suppl 1():S128-9. PubMed ID: 8547504 [No Abstract] [Full Text] [Related]
63. [Severe bacterial infections after prophylactic suppression of Pneumocystis carinii in HIV infected patients after CD4 lymphocyte recovery]. Boix V; Murcia JM; Merino E; Portilla J Med Clin (Barc); 2002 Jun; 118(20):796-7. PubMed ID: 12049699 [No Abstract] [Full Text] [Related]
64. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection. Kreuz W; Güngör T; Lotz C; Funk M; Kornhuber B Lancet; 1990 Aug; 336(8713):508-9. PubMed ID: 1975015 [No Abstract] [Full Text] [Related]
65. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Mofenson LM; Moye J; Korelitz J; Bethel J; Hirschhorn R; Nugent R Pediatr Infect Dis J; 1994 Jun; 13(6):477-84. PubMed ID: 8078734 [TBL] [Abstract][Full Text] [Related]
66. [Pulmonary pneumocystosis revealing HIV infection]. Luchon L; Couderc LJ; Stern M; Friard S; Caubarrere I Presse Med; 1994 May; 23(20):951. PubMed ID: 7937635 [No Abstract] [Full Text] [Related]
67. Anaphylactic-like reaction from trimethoprim-sulfamethoxazole in a patient with AIDS. Persichino J; Sutjita M Int J STD AIDS; 2016 Jun; 27(7):595-7. PubMed ID: 25999169 [TBL] [Abstract][Full Text] [Related]
68. Successful treatment of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in hypersensitive AIDS patients. Gibbons RB; Lindauer JA JAMA; 1985 Mar; 253(9):1259-60. PubMed ID: 3871490 [No Abstract] [Full Text] [Related]
69. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention. MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543 [TBL] [Abstract][Full Text] [Related]
70. Discontinuing prophylaxis against Pneumocystis carinii pneumonia. Bender MA; Sax PE N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364 [No Abstract] [Full Text] [Related]
71. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus. Wilfert CM; Masur H; Gross PA; Kaplan JE; Holmes KK; Phair JP; Simonds RJ Clin Infect Dis; 1995 Aug; 21 Suppl 1():S132-3. PubMed ID: 8547506 [No Abstract] [Full Text] [Related]
72. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3. Lim L ; Street AC; Lewin SR AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267 [No Abstract] [Full Text] [Related]
73. Primary prophylaxis against Pneumocystis carinii pneumonia. Tarabey R N Engl J Med; 1993 May; 328(20):1499. PubMed ID: 8097561 [No Abstract] [Full Text] [Related]
74. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Piketty C; Gilquin J; Kazatchkine MD J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921 [No Abstract] [Full Text] [Related]
75. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. JAMA; 1989 Jul; 262(3):335-9. PubMed ID: 2525628 [No Abstract] [Full Text] [Related]
77. Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia. Glatt AE South Med J; 1994 Apr; 87(4):429-30. PubMed ID: 8153765 [TBL] [Abstract][Full Text] [Related]
78. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV. Connor E; Bagarazzi M; McSherry G; Holland B; Boland M; Denny T; Oleske J JAMA; 1991 Apr; 265(13):1693-7. PubMed ID: 1672168 [TBL] [Abstract][Full Text] [Related]
79. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375 [TBL] [Abstract][Full Text] [Related]
80. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. Fisher RG; Nageswaran S; Valentine ME; McKinney RE AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]